Opinion statement
Women generally have more complaints about sleep, compared with men of the same age. At various stages of reproduction, the reasons for these complaints become rather obvious—menstrual cramps and discomfort, pregnancy and postpartum factors, and menopausal hot flashes can fragment sleep. In addition, there are lifestyle factors, such as going to bed late and getting up early in order to attend to various family responsibilities, restricting the time allowed for sleep. Factors outside a woman’s control, such as caregiving for sick family members during the night, can also result in disrupted sleep patterns, with little opportunity to make up for the lost sleep on weekends or days off. This article discusses the types of insomnia commonly experienced by women during key reproductive stages of life and proposes gender-specific assessment and management strategies. Pharmacologic management of sleep problems is useful for brief episodes of insomnia, but not usually desirable during pregnancy and lactation, or for management of chronic insomnia. For most women, regardless of reproductive stage, nonpharmacologic strategies that involve behavioral therapies, or short-term focused use of hypnotics at key time points, are more effective for quality of life than is long-term use of pharmacologic interventions.
Similar content being viewed by others
References and Recommended Reading
National Sleep Foundation: 1998 Women and Sleep Poll. http://www.sleepfoundation.org/sleeplibrary. Accessed March 4, 2006.
Baker FC, Driver HA, Rogers GG, et al.: High nocturnal body temperatures and disturbed sleep in women with primary dysmenorrhea. Am J Physiol 1999, 40:E1013-E1021.
Tworoger SS, Davis S, Vitiello MV, et al.: Factors associated with objective (actigraphic) and subjective sleep quality in young adult women. J Psychosom Res 2005, 59:11–19. A large sample with objective measures of daily sleep patterns in the home setting during 7 days of the luteal phase of the menstrual cycle.
Touzet S, Rabilloud M, Boehringer H, et al.: Relationship between sleep and secretion of gonadotropin and ovarian hormones in women with normal cycles. Fertil Steril 2002, 77:738–744.
Suzuki H, Uchiyama M, Shibui K, et al.: Long-term rectal temperature measurements in a patient with menstrual-associated sleep disorder. Psychiatry Clin Neurosci 2002, 56:475–478.
Lee KA, Zaffke ME, Barette-Beebe L: Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. J Womens Health Gend Based Med 2001, 10:335–341. Although the sample size is small, this is the first descriptive study of changes in serum levels of folate and iron from prepregnancy to 4 weeks postpartum, comparing women with and without RLS.
Roffe C, Sills S, Crome P, Jones P: Randomized, crossover placebo controlled trial of magnesium citrate in the treatment of chronic persistent leg cramps. Med Sci Monit 2002, 8:CR326-CR330. Six weeks of treatment or placebo with adequate 2-week wash-out period in adults with persistent leg cramps were recorded in a cramp diary; pregnant women were excluded from participation.
Manconi M, Govoni V, DeVito A, et al.: Pregnancy as a risk factor for restless legs syndrome. Sleep Med 2004, 5:305–308.
Sadan O, Shushas S, Eldar I, et al.: The effects of an external nasal dilator on labor. Am J Rhinol 2005, 19:221–224.
Krakow B, Melendrez D, Sisley B, et al.: Nasal dilator strip therapy for chronic sleep-maintenance insomnia and symptoms of sleep-disordered breathing: a randomized controlled trial. Sleep Breath 2006, 10:16–28.
Edwards N, Middleton PG, Blyton DM, Sullivan CE: Sleep disordered breathing and pregnancy. Thorax 2002, 57:555–558.
Charlton BG: Letter to the Editor. Self-management and pregnancy--safe interventions for panic, phobia, and other anxiety-disorders might include over-thecounter (OTC) ‘SSRI’ antihistamines such as diphenhydramine and chlorpheniramine. Acta Psychiatr Scan 2005, 112:323.
Briggs GG, Freeman RK, Yaffe SJ: Drugs in Pregnancy and Lactation. Philadelphia: Lippincott Williams & Wilkins; 2002. A key reference for evidence-based drug risk classifications for childbearing women.
Manconi M, Ferini-Strambi L, Hening WA: Response to clinical corners case (Sleep Medicine 6/2:83-4): pregnancy associated with daytime sleepiness and nighttime restlessness. Sleep Med 2005, 6:477–478. Presents current thought about treatment of RLS during pregnancy.
Earley CJ: Response to clinical corners case (Sleep Medicine 6/2:83-4): pregnancy associated with daytime sleepiness and nighttime restlessness. Sleep Med 2005, 6:475.
Blyton DM, Sullivan CE, Edwards N: Lactation is associated with an increase in slow-wave sleep in women. J Sleep Res 2002, 11:297–303. The first study to demonstrate that polysomnographyrecorded sleep differs for lactating women compared with nonlactating women.
Kennedy HP, Beck CT, Driscoll JW: A light in the fog: caring for women with postpartum depression. J Midwifery Womens Health 2002, 47:318–330.
Hiscock H, Wake M: Randomised control trial of behavioural infant sleep intervention to improve sleep and maternal mood. BMJ 2002, 324:1062–1065.
Cohen LS, Altshuler LL, Harlow BL, et al.: Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006, 295:499–507. A prospective monthly assessment of relapse risk in pregnant women enrolled before 16 weeks gestation, compared with those who continued to take their medication during pregnancy.
Corral M, Kuan A, Kostaras D: Bright light therapy’s effect on postpartum depression. Am J Psychiatry 2000, 157:303–304.
Parry BL, Curran ML, Stuenkel CA, et al.: Can critically timed sleep deprivation be useful in pregnancy and postpartum depression? J Affect Disord 2000, 60:201–212.
Kravitz HM, Ganz PA, Bromberger J, et al.: Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 2003, 10:19–28. Large federally funded study of midlife women in the United States; sleep assessed by one self-report item in telephone interview.
Ford K, Sowers M, Crutchfield M, et al.: A longitudinal study of the predictors of prevalence and severity of symptoms commonly associated with menopause. Menopause 2005, 12:308–317. Part of a large Michigan bone-health study that included a 10-year longitudinal component with a self-reported sleep measure and adequate sample of midlife women.
Young T, Rabago D, Zgierska A, et al.: Objective and subjective sleep quality in premenopausal, perimenopausal, and postmenopausal women in the Wisconsin sleep cohort study. Sleep 2003, 26:667–672. A large epidemiologic study that included polysomnography measures of sleep in midlife women.
Freedman RR, Roehrs TA: Lack of sleep disturbance from menopausal hot flashes. Fertil Steril 2004, 82:138–144. A carefully controlled polysomnography laboratory study of sleep and objective measures of hot flashes.
Thompson J, Oswald I: Effect of estrogen on the sleep, mood, and anxiety of menopausal women. BMJ 1977, 2:1317–1319.
Schiff I, Regestein Q, Tulchnisky D, Ryan K: Effects of estrogens on sleep and psychological state of hypogonadal women. JAMA 1979, 242:2405–2407.
Purdie DW, Empson JA, Crichton C, MacDonald L: Hormone replacement therapy, sleep quality, and psychological wellbeing. Brit J Obstet Gynaecol 1995, 102:735–739.
Montplaisir J, Lorraine J, Denesle R, Petit D: Sleep in menopause: differential effects of two forms of hormone replacement therapy. Menopause 2001, 8:10–16. A carefully controlled laboratory study that included polysomnography-recorded sleep.
North American Menopause Society: Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004, 11:11–33. An evidence-based position paper that synthesizes pharmacologic and nonpharmacologic treatment options for menopausal vasomotor symptoms.
Freedman RR: Hot flashes: behavioral treatments, mechanisms, and relation to sleep. Am J Med 2005, 118:124S-130S. An excellent review of thermoregulation and etiology of hot flashes.
Tworoger SS, Yasui U, Vitiello MV, et al.: Effects of a yearlong moderate-intensity exercise and stretching intervention on sleep quality in postmenopausal women. Sleep 2003, 26:830–836. Demonstrated long-term improvement in self-reported sleep parameters and less use of sleep medication in a sample of sedentary obese postmenopausal women; hot flashes were not addressed.
Murtaugh DR, Greenwood KM: Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol 1995, 63:79–89.
Morin CM, Culbert JP, Schwartz SM: Nonpharmacological intervention for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 1994, 151:1172–1180. A thorough synthesis of outcomes from cognitive-behavioral intervention studies in primary insomnia that support longterm efficacy compared with pharmacologic agents, particular in the elderly and those with primary insomnia.
Harvey AG, Tang NKY: Cognitive behavior therapy for primary insomnia: can we rest yet? Sleep Med Rev 2003, 7:237–262.
Kronenberg F, Fugh-Berman A: Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 2002, 137:805–813.
Kessel B, Kronenberg F: The role of complementary and alternative medicine in management of menopausal symptoms. Endocrinol Metab Clin North Am 2004, 33:717–739.
Newton KM, Reed SD, Grothaus L, et al.: The herbal alternatives for menopause (HALT) study: background and study design. Maturitas 2005, 52:134–146.
Nelson HD, Vesco KK, Haney E, et al.: Nonhormonal therapies for menopausal hot flashes. Systematic review and meta-analysis. JAMA 2006, 295:2057–2071. The most thorough and current synthesis of research studies on non-hormonal agents for the treatment of hot flashes; 43 studies met inclusion criteria.
Sun J: Morning/evening menopausal formula relieves menopausal symptoms: a pilot study. J Altern Complement Med 2003, 9:403–409.
Dorsey CM, Lee KA, Scharf MB: Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study. Clin Ther 2004, 26:1578–1586. A multisite study of symptomatic menopausal women in which a short-acting non-benzodiazepine medication was taken every night for 4 weeks compared with nightly placebo; included self-report sleep assessments on a daily diary basis.
Loprinzi CL, Stearns V, Barton D: Centrally active nonhormonal hot flash therapies. Am J Med 2005, 118(12 Suppl 2):118–123. Brief review of nonhormonal options for treatment of hot flashes.
Pandya KJ, Morrow GR, Roscoe JA, et al.: Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet 2005, 366:818–824. Compared with placebo and gabapentin 300 mg/day, diary recordings of flash frequency were reduced with gabapentin 900 mg/day administered for 8 weeks in women with breast cancer.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lee, K.A. Sleep dysfunction in women and its management. Curr Treat Options Neurol 8, 376–386 (2006). https://doi.org/10.1007/s11940-006-0027-5
Issue Date:
DOI: https://doi.org/10.1007/s11940-006-0027-5